Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor

Details Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor

C - Chemistry, Metallurgy

12

N

C12N 9/64 (2006.01) C07K 7/08 (2006.01) C07K 14/705 (2006.01) C07K 14/81 (2006.01) C12N 9/99 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2140127

Disclosed are molecules which inhibit the proteolytic activity of cysteine proteases such as Cathepsin H, Cathepsin L and papain, and methods for using molecules which have the biological properties of cytotoxic T-lymphocyte antigen for inhibiting cysteine proteases and inhibiting proteoglycan degration.

On divulgue des molécules qui inhibent l'activité protéolytique des protéases à cystéine comme la cathepsine H, la cathepsine L et la papaïne, et des méthodes pour utiliser les molécules qui ont les propriétés biologiques de l'antigène du lymphocyte T cytotoxique pour inhiber les protéases à cystéine et pour inhiber la dégradation des protéoglycanes.

Affiliated with

Also associated with

Rating

Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1727863